Eravacycline (Xerava)

Synonym(s): TP-434

Class: Tetracycline

Spectrum of activity:	Gram-positive  &  Gram-negative
Details of activity:	Complicated intra-abdominal infections (cIAI).
Description:	Synthetic tetracycline derivative
Institute where first reported:	Tetraphase Pharmaceuticals, USA
Year first mentioned:	2012
Highest developmental phase:	Approved by FDA in 2018
Development status:	Approved

Chemical structure(s):
Canonical SMILES:	CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=C(C(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)NC(=O)CN5CCCC5)F
Isomeric SMILES:	CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=C(C(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)NC(=O)CN5CCCC5)F
InChI:	InChI=1S/C27H31FN4O8/c1-31(2)20-13-8-11-7-12-14(28)9-15(30-16(33)10-32-5-3-4-6-32)21(34)18(12)22(35)17(11)24(37)27(13,40)25(38)19(23(20)36)26(29)39/h9,11,13,20,34-35,38,40H,3-8,10H2,1-2H3,(H2,29,39)(H,30,33)/t11-,13-,20-,27-/m0/s1
InChI Key:	AKLMFDDQCHURPW-ISIOAQNYSA-N
Structure link:	https://pubchem.ncbi.nlm.nih.gov/compound/54726192

External links:
Guide to Pharmacology:	eravacycline
Main Source:	https://www.tphase.com/products/xerava
Citations:	http://aac.asm.org/content/57/11/5548.full http://aac.asm.org/content/59/4/2426.full http://pubs.acs.org/doi/abs/10.1021/jm201467r?journalCode=jmcmar